Evidence map›Paper›PMID 38143262›Full record

ArticleEuropean journal of hybrid imaging2023

Exploring the applicability of a lesion segmentation method on [

Germán Pitarch, Yamila Rotstein Habarnau, Roxana Chirico, Brenda Konowalik, Amalia Pérez, Alejandro Valda, María Bastianello

Abstract read
In one paragraph

Article in European journal of hybrid imaging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Germán PitarchSección de Imágenes Moleculares y Terapia Metabólica, Hospital Universitario CEMIC, Ciudad Autónoma de Buenos Aires, Argentina.ORCID http://orcid.org/0000-0002-5738-3570
Yamila Rotstein HabarnauCentro Universitario de Imágenes Médicas, Escuela de Ciencia y Tecnología, Universidad Nacional de San Martín, Buenos Aires, Argentina.
Roxana ChiricoSección de Imágenes Moleculares y Terapia Metabólica, Hospital Universitario CEMIC, Ciudad Autónoma de Buenos Aires, Argentina.ORCID http://orcid.org/0000-0002-3278-0764
Brenda KonowalikSección de Imágenes Moleculares y Terapia Metabólica, Hospital Universitario CEMIC, Ciudad Autónoma de Buenos Aires, Argentina.ORCID http://orcid.org/0000-0002-2892-9677
Amalia PérezCentro Universitario de Imágenes Médicas, Escuela de Ciencia y Tecnología, Universidad Nacional de San Martín, Buenos Aires, Argentina.ORCID http://orcid.org/0000-0001-9500-3236
Alejandro ValdaCentro Universitario de Imágenes Médicas, Escuela de Ciencia y Tecnología, Universidad Nacional de San Martín, Buenos Aires, Argentina. avalda@unsam.edu.ar.ORCID http://orcid.org/0000-0002-3151-2119
María BastianelloSección de Imágenes Moleculares y Terapia Metabólica, Hospital Universitario CEMIC, Ciudad Autónoma de Buenos Aires, Argentina.ORCID http://orcid.org/0000-0002-3254-1800

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeThe determination of the total metabolic tumour volume based on [

methodsWe enrolled 23 adult patients with DLBCL confirmed in II-IV stages without nervous system compromise. All patients were scanned using [

resultsBoth, liver, and bone marrow can be indistinctly taken as reference tissue. The SUV threshold for a voxel to be considered as belonging to a lesion is expressed in terms of a percentage relative to the patient's uptake in the reference tissue. Found thresholds were: for liver, 62%, 33%, 27%; and for bone marrow, 35%, 21% and 22%, for baseline, iPET and fPET stages, respectively. The relative threshold throughout the treatment has a decreasing tendency along the stages.

conclusionBased on the results obtained with [

Indexed as

Fluorine-18 fluorothymidineNon-Hodgkin’s lymphomaPET/CTSegmentationTumour proliferation volume

Identifiers

PMID38143262
PMCPMC10749290

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.